B. Riley analyst issues BUY recommendation for MRVL on August 19, 2026 05:03PM ET. The previous analyst recommendation was Buy.MRVL was trading at $233.63 at issue of the analyst recommendation.The overall analyst consensus : BUY.Current analyst recommendations are : 60 - Buy, 12 - Hold, 1 - Sell recommendations .Historical Analyst RecommendationsLatest 10 recommendationsReport DateAnalyst...
Devin McDermott from Morgan Stanley issued a price target of $151.00 for COP on 2026-08-19 13:18:18.The...
from Morgan Stanley issued a price target of $177.00 for XOM on 2026-08-19 13:16:55.The adjusted price...
from Morgan Stanley issued a price target of $218.00 for CVX on 2026-08-19 13:16:42.The adjusted price...
Oppenheimer analyst issues CAUTIOUS recommendation for WMT on August 19, 2026 02:23PM ET. The previous analyst...
Devin McDermott from Morgan Stanley issued a price target of $151.00 for COP on 2026-08-19 13:18:18.The adjusted price target was set to $151.00.At the time of the announcement, COP was...
from Morgan Stanley issued a price target of $177.00 for XOM on 2026-08-19 13:16:55.The adjusted price target was set to $177.00.At the time of the announcement, XOM was trading at...
from Morgan Stanley issued a price target of $218.00 for CVX on 2026-08-19 13:16:42.The adjusted price target was set to $218.00.At the time of the announcement, CVX was trading at...
from Argus Research issued a price target of $114.00 for CVS on 2026-08-19 12:45:11.The adjusted price target was set to $114.00.At the time of the announcement, CVS was trading at...
Bill Selesky from Argus Research issued a price target of $153.00 for COP on 2026-08-19 12:43:32.The adjusted price target was set to $153.00.At the time of the announcement, COP was...
In the first quarter of 2025, the company faced revenue declines, largely due to Paxlovid, while operational expenses surged. Management is committed to enhancing R&D productivity and optimizing capital allocation,...
In a landscape of fluctuating markets and regulatory uncertainties, the company experienced a remarkable revenue surge, reaching $36,077 million. Despite operational challenges, net income stood at $7,713 million. Management emphasized...
In the bustling corridors of Merck, management reflects on a transformative quarter. With net income rising to 5,085 million, the company celebrates strategic wins in oncology and diabetes, driven by...
In 2025, the company embraced growth through increased research and development, despite rising operating expenses. A net income of $24,780 million marked a decline, reflecting challenges in a fluctuating market....
In the first quarter of 2025, the company experienced a 9% revenue growth, fueled by increased sales and services. Operating expenses rose, reflecting evolving cost structures, while net income showed...
Truist Bank has recently announced a strategic partnership with Trovata, a leading provider of bank application programming interfaces (APIs) and enterprise cash management services. The partnership is expected to greatly...
Yesterday, two Exchange-Traded Funds (ETFs) captured the attention of investors due to their unusually high trading volumes. These two highly popular ETFs, the Nasdaq-100 ETF and the bonds ETF, have...
Truist Bank, one of the largest financial institutions in the United States, has announced a strategic partnership with Trovata, a leading provider of bank application programming interfaces (APIs) and enterprise...
Amazon, the retail giant that generates a staggering $540 billion in annual revenue, is scheduled to report its third-quarter earnings on October 26. Despite already gaining over 50% in stock...
Verizon's stock is experiencing a tremendous surge, poised to have its best day in 15 years. The telecom giant exceeded analyst expectations both in terms of revenue and profit margins....
